PL2423315T3 - Sposób osiągania lepszej ekspresji polipeptydu - Google Patents

Sposób osiągania lepszej ekspresji polipeptydu

Info

Publication number
PL2423315T3
PL2423315T3 PL11163033T PL11163033T PL2423315T3 PL 2423315 T3 PL2423315 T3 PL 2423315T3 PL 11163033 T PL11163033 T PL 11163033T PL 11163033 T PL11163033 T PL 11163033T PL 2423315 T3 PL2423315 T3 PL 2423315T3
Authority
PL
Poland
Prior art keywords
polypeptide expression
achieving improved
improved polypeptide
achieving
expression
Prior art date
Application number
PL11163033T
Other languages
English (en)
Inventor
Johannes Andries Roubos
Van Noël Nicolaas Maria Elisabeth Peij
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of PL2423315T3 publication Critical patent/PL2423315T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C12N9/242—Fungal source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL11163033T 2006-06-29 2007-06-15 Sposób osiągania lepszej ekspresji polipeptydu PL2423315T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06076328 2006-06-29
EP11163033.1A EP2423315B1 (en) 2006-06-29 2007-06-15 A method for achieving improved polypeptide expression
EP07765439A EP2035561A1 (en) 2006-06-29 2007-06-15 A method for achieving improved polypeptide expression

Publications (1)

Publication Number Publication Date
PL2423315T3 true PL2423315T3 (pl) 2015-06-30

Family

ID=37199000

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11163033T PL2423315T3 (pl) 2006-06-29 2007-06-15 Sposób osiągania lepszej ekspresji polipeptydu

Country Status (12)

Country Link
US (2) US8812247B2 (pl)
EP (2) EP2035561A1 (pl)
JP (1) JP5250850B2 (pl)
CN (1) CN101490262B (pl)
AU (1) AU2007263880A1 (pl)
BR (1) BRPI0713795B1 (pl)
CA (1) CA2657975A1 (pl)
DK (1) DK2423315T3 (pl)
EA (1) EA015925B1 (pl)
ES (1) ES2534282T3 (pl)
PL (1) PL2423315T3 (pl)
WO (1) WO2008000632A1 (pl)

Families Citing this family (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10260805A1 (de) * 2002-12-23 2004-07-22 Geneart Gmbh Verfahren und Vorrichtung zum Optimieren einer Nucleotidsequenz zur Expression eines Proteins
WO2008019036A2 (en) * 2006-08-04 2008-02-14 Pharmathene Inc. Long half-life recombinant butyrylcholinesterase
US20100112638A1 (en) 2007-02-15 2010-05-06 Cornelis Maria Jacobus Sagt Recombinant host cell for the production of a compound of interest
WO2009005564A2 (en) * 2007-06-29 2009-01-08 The Regents Of The University Of California Cellulose- and hemicellulose-degradation enzyme -encoding nucleotide sequences with refined translational kinetics and methods of making same
WO2009030254A1 (en) * 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
WO2009065777A1 (en) 2007-11-20 2009-05-28 Dsm Ip Assets B.V. Dicarboxylic acid production in a filamentous fungus
WO2009065778A1 (en) 2007-11-20 2009-05-28 Dsm Ip Assets B.V. Succinic acid production in a eukaryotic cell
CN102016053A (zh) * 2008-02-15 2011-04-13 帝斯曼知识产权资产管理有限公司 生产二羧酸的方法
EP2250263A1 (en) * 2008-03-07 2010-11-17 DSM IP Assets B.V. A pentose sugar fermenting cell
JP5625199B2 (ja) * 2008-03-07 2014-11-19 ディーエスエム アイピー アセッツ ビー．ブイ． ペントース糖発酵細胞
CN102026960B (zh) 2008-03-11 2014-07-16 帝斯曼知识产权资产管理有限公司 从5-甲酰缬草酸制备6-氨基己酸
CN109468348B (zh) 2008-03-11 2023-05-16 基因组股份公司 己二酸酯或硫代酯合成
EP2123768A1 (en) 2008-05-20 2009-11-25 DSM IP Assets B.V. Preparation of (Z)-6,7-dihydro-1H-azepin-2(5H)-one
EP2123767A1 (en) 2008-05-20 2009-11-25 DSM IP Assets B.V. Preparation of epsilon-caprolactam via lysine cyclisation
CN102089436A (zh) 2008-07-08 2011-06-08 帝斯曼知识产权资产管理有限公司 通过在低pH下发酵生产二羧酸
CN102741421B (zh) 2009-03-10 2015-03-25 帝斯曼知识产权资产管理有限公司 用于提高多肽产率的方法
WO2010102976A1 (en) 2009-03-10 2010-09-16 Dsm Ip Assets B.V. Pregastric esterase and derivatives thereof
TW201037078A (en) 2009-03-11 2010-10-16 Dsm Ip Assets Bv Preparation of alpha-ketopimelic acid
EP2419518A1 (en) 2009-04-15 2012-02-22 DSM IP Assets B.V. Dicarboxylic acid production process
EP2421986A1 (en) 2009-04-22 2012-02-29 DSM IP Assets B.V. Process for the production of a recombinant polypeptide of interest
UA108853C2 (uk) 2009-07-10 2015-06-25 Спосіб ферментації галактози
EP3293264A1 (en) 2009-07-22 2018-03-14 DSM IP Assets B.V. Improved host cell for the production of a compound of interest
CA2768614A1 (en) 2009-07-24 2011-01-27 Dsm Ip Assets B.V. Process for the preparation of 1,4-butanediamine via n-acyl or n-guanidyl protected 1,4-butanediamine precursors
EA026438B1 (ru) 2009-08-27 2017-04-28 ДСМ АйПи АССЕТС Б.В. Способ ферментативного получения дикарбоновых кислот
WO2011026877A1 (en) 2009-09-03 2011-03-10 Dsm Ip Assets B.V. Baking enzyme composition as ssl replacer
WO2011064151A1 (en) 2009-11-24 2011-06-03 Dsm Ip Assets B.V. Process for the crystallization of succinic acid
EP2336310A1 (en) 2009-12-16 2011-06-22 Isobionics B.V. Valencene synthase
AU2010340358B2 (en) 2009-12-21 2014-07-24 Pharmathene, Inc. Recombinant butyrylcholinesterases and truncates thereof
JP5521236B2 (ja) * 2009-12-22 2014-06-11 独立行政法人産業技術総合研究所 発現予測装置および発現予測方法
US20160186188A1 (en) * 2010-02-09 2016-06-30 Rutgers, The State University Of New Jersey Methods for altering polypeptide expression and solubility
WO2011157717A1 (en) 2010-06-14 2011-12-22 Dsm Fine Chemicals Austria Nfg. Gmbh & Co Kg Novel polypeptides having nad(p)h oxidase activity and the use thereof
CA2803222A1 (en) 2010-07-01 2012-01-05 Dsm Ip Assets B.V. A method for the production of a compound of interest
PT2593556T (pt) 2010-07-14 2017-12-11 Dpx Holdings Bv Método enzimático de (r)-aminação seletiva
WO2012031910A2 (en) 2010-09-10 2012-03-15 Dsm Ip Assets B.V. Method for preparing alpha-ketopimelic acid by c1-elongation
EA201300325A1 (ru) 2010-09-10 2013-08-30 ДСМ АйПи АССЕТС Б.В. Получение 6-аминокапроновой кислоты из альфа-кетопимелиновой кислоты
EP2619314A1 (en) 2010-09-24 2013-07-31 DSM IP Assets B.V. Dicarboxylic acid production process
EP2495304A1 (en) 2010-12-03 2012-09-05 DSM IP Assets B.V. Dicarboxylic acid production in a yeast cell
WO2012089613A1 (en) 2010-12-28 2012-07-05 Dsm Ip Assets B.V. Process to increase the production of a succinyl-coa derived compound
CN103596970A (zh) 2011-03-11 2014-02-19 帝斯曼知识产权资产管理有限公司 载体-宿主系统
WO2012131059A1 (en) 2011-04-01 2012-10-04 Dsm Ip Assets B.V. Preparation of 5-formyl valeric acid from alpha-ketopimelic acid
EP2537926A1 (en) 2011-06-21 2012-12-26 Isobionics B.V. Valencene synthase
PL2726624T3 (pl) 2011-07-01 2017-06-30 Dsm Ip Assets B.V. Sposób wytwarzania kwasów dikarboksylowych komórki zatrudniających grzybiczych
EA201490275A1 (ru) * 2011-07-13 2014-06-30 Эметис, Инк. Композиции и способы получения изопрена
WO2013007820A1 (en) 2011-07-14 2013-01-17 Dsm Ip Assets B.V. Screening method
AR087423A1 (es) 2011-08-04 2014-03-19 Dsm Ip Assets Bv Celula capaz de fermentar azucares pentosas
EP2554668A1 (en) 2011-08-04 2013-02-06 DSM IP Assets B.V. A pentose sugar fermenting cell
EP2800809B1 (en) 2012-01-05 2018-03-07 Glykos Finland Oy Protease deficient filamentous fungal cells and methods of use thereof
ES2546630T3 (es) 2012-01-30 2015-09-25 Dsm Ip Assets B.V. Alfa-amilasa
CN114107352A (zh) 2012-04-17 2022-03-01 弗·哈夫曼-拉罗切有限公司 使用修饰的核酸表达多肽的方法
DK2852610T3 (en) 2012-05-23 2018-09-03 Glykos Finland Oy PRODUCTION OF FUCOSYLED GLYCOPROTEIN
US20150147365A1 (en) 2012-05-31 2015-05-28 Dsm Ip Assets B.V. Oral preparation
BR112015001155A2 (pt) 2012-07-18 2017-06-27 Isobionics B V célula hospedeira rhodobacter respectivo uso e método para preparar monoterpeno ou sesquiterpeno
MX357482B (es) 2012-07-19 2018-07-11 Dsm Ip Assets Bv Cepa deficiente en agse.
WO2014018552A1 (en) 2012-07-24 2014-01-30 Bp Corporation North America Inc. Xylose isomerases and their uses
IN2015DN01042A (pl) 2012-08-28 2015-06-26 Dsm Ip Assets Bv
WO2014033018A1 (en) 2012-08-28 2014-03-06 Dsm Ip Assets B.V. Yeast strains engineered to produce ethanol from acetate
US20140244228A1 (en) * 2012-09-19 2014-08-28 Agency For Science, Technology And Research Codon optimization of a synthetic gene(s) for protein expression
WO2014044782A1 (en) 2012-09-19 2014-03-27 Dsm Ip Assets B.V. Cell modification method using essential genes as markers and optionally recycling these
ES2717682T3 (es) 2012-10-16 2019-06-24 Dsm Ip Assets Bv Células con conversión mejorada de pentosas
WO2014142647A1 (en) 2013-03-14 2014-09-18 Wageningen Universiteit Fungals strains with improved citric acid and itaconic acid production
DK3019602T3 (en) 2013-07-10 2018-11-12 Glykos Finland Oy MULTIPLE PROTEASE-DEFECTED FILAMENTARY FUNGAL CELLS AND PROCEDURES FOR USE THEREOF
WO2015053871A2 (en) 2013-08-26 2015-04-16 MabVax Therapeutics, Inc. NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWISa
AR097480A1 (es) 2013-08-29 2016-03-16 Dsm Ip Assets Bv Células de levadura convertidoras de glicerol y ácido acético con una conversión de ácido acético mejorada
WO2015082488A1 (en) 2013-12-02 2015-06-11 Dsm Ip Assets B.V. Ice structuring protein
WO2015177153A1 (en) 2014-05-19 2015-11-26 Dsm Ip Assets B.V. Proline-specific endoprotease
WO2015177152A1 (en) 2014-05-19 2015-11-26 Dsm Ip Assets B.V. Proline-specific endoprotease
MX375798B (es) 2014-05-19 2025-03-07 Dsm Ip Assets Bv Endoproteasa específica para prolina.
KR102226248B1 (ko) 2014-06-04 2021-03-12 바이오엔테크 리서치 앤드 디벨롭먼트 인코포레이티드 강글리오사이드 ｇｄ２에 대한 사람 단클론 항체
AU2015293949B2 (en) 2014-07-21 2019-07-25 Teknologian Tutkimuskeskus Vtt Oy Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
US11396665B2 (en) 2015-01-06 2022-07-26 Dsm Ip Assets B.V. CRISPR-CAS system for a filamentous fungal host cell
CN108064287A (zh) 2015-01-06 2018-05-22 帝斯曼知识产权资产管理有限公司 用于解脂酵母宿主细胞的crispr-cas系统
EP3242949B1 (en) 2015-01-06 2021-11-03 DSM IP Assets B.V. A crispr-cas system for a yeast host cell
EP3259361A1 (en) 2015-02-16 2017-12-27 DSM IP Assets B.V. Process for producing itaconic acid under anaerobic conditions
AR104205A1 (es) 2015-04-09 2017-07-05 Dsm Ip Assets Bv Fosfolipasa c
WO2016193292A1 (en) 2015-06-02 2016-12-08 Dsm Ip Assets B.V. Use of ice structuring protein afp19 expressed in filamentous fungal strains for preparing food
US10724040B2 (en) 2015-07-15 2020-07-28 The Penn State Research Foundation mRNA sequences to control co-translational folding of proteins
WO2017050652A1 (en) 2015-09-25 2017-03-30 Dsm Ip Assets B.V. Asparaginase
EP4361240A3 (en) 2015-11-17 2024-07-31 DSM IP Assets B.V. Preparation of a stable beer
WO2017201731A1 (en) 2016-05-27 2017-11-30 Beijing Vdjbio Co., Ltd. Antibodies, composition and kits comprising same, and methods of use thereof
US10829748B2 (en) 2016-06-10 2020-11-10 Dsm Ip Assets B.V. Mutant lipase and use thereof
CA3030605A1 (en) 2016-07-13 2018-01-18 Dsm Ip Assets B.V. Malate dehyrogenases
JP2019520069A (ja) 2016-07-13 2019-07-18 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 藻類宿主細胞用のｃｒｉｓｐｒ−ｃａｓシステム
WO2018019948A1 (en) 2016-07-29 2018-02-01 Dsm Ip Assets B.V. Polypeptides having cellulolytic enhancing activity and uses thereof
CN106650307B (zh) * 2016-09-21 2019-04-05 武汉伯远生物科技有限公司 一种基于密码子对使用频度的基因密码子优化方法
DK3516056T3 (da) 2016-09-23 2025-02-17 Dsm Ip Assets Bv Et guide-rna-ekspressionssystem til en værtscelle
US10918113B2 (en) 2016-12-21 2021-02-16 Dsm Ip Assets B.V. Lipolytic enzyme variants
WO2018114912A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
WO2018114938A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
WO2018114940A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
CN110088274A (zh) 2016-12-22 2019-08-02 帝斯曼知识产权资产管理有限公司 谷胱甘肽还原酶
US20190376067A1 (en) * 2017-02-13 2019-12-12 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for multiplexed trackable genomically-engineered polypeptides
NL2018457B1 (en) 2017-03-02 2018-09-21 Isobionics B V Santalene Synthase
CN110431224A (zh) 2017-03-13 2019-11-08 帝斯曼知识产权资产管理有限公司 锌双核簇转录调控因子缺陷型菌株
CN107353327A (zh) * 2017-03-30 2017-11-17 南京百斯杰生物工程有限公司 植酸酶在黑曲霉中表达
US20200032252A1 (en) 2017-04-06 2020-01-30 Dsm Ip Assets B.V. Self-guiding integration construct (sgic)
CN110070913B (zh) * 2017-07-25 2023-06-27 南京金斯瑞生物科技有限公司 一种基于免疫算法的密码子优化方法
NL2019473B1 (en) 2017-09-01 2019-03-11 Isobionics B V Terpene Synthase producing patchoulol and elemol, and preferably also pogostol
US11447714B2 (en) 2017-09-26 2022-09-20 Bunge Global Innovation, Llc Enzymatic removal of chlorophyll substrates from triacylglycerol-based oils
CN111630069B (zh) 2017-10-13 2024-05-31 勃林格殷格翰国际有限公司 针对Thomsen-nouvelle(Tn)抗原的人抗体
EP3728603A2 (en) 2017-12-20 2020-10-28 DSM IP Assets B.V. A method for genome editing in a host cell
US11944104B2 (en) 2018-04-05 2024-04-02 Dsm Ip Assets B.V. Variant maltogenic alpha-amylase
EP3790969A1 (en) 2018-05-09 2021-03-17 DSM IP Assets B.V. Crispr transient expression construct (ctec)
US20230250406A1 (en) 2018-05-18 2023-08-10 Dsm Ip Assets B.V. Mutant lipase and use thereof
WO2019219903A2 (en) 2018-05-18 2019-11-21 Dsm Ip Assets B.V. Mutant lipase and use thereof
US12195769B2 (en) 2018-06-19 2025-01-14 Dsm Ip Assets B.V. Lipolytic enzyme variants
TWI802728B (zh) * 2018-07-30 2023-05-21 大陸商南京金斯瑞生物科技有限公司 密碼子優化方法、包括其之系統及電子裝置、其核酸分子及使用其之蛋白質表現方法
WO2020037085A1 (en) * 2018-08-15 2020-02-20 Zymergen Inc. Bioreachable prediction tool with biological sequence selection
CA3106384A1 (en) 2018-11-02 2020-05-07 Beijing Vdjbio Co., Ltd. Modified ctla4 and methods of use thereof
BR112021009177A2 (pt) 2018-11-15 2021-10-26 Dsm Ip Assets B.V. Produção aprimorada de riboflavina
US20220056460A1 (en) 2018-12-05 2022-02-24 Dsm Ip Assets B.V. Crispr guide-rna expression strategies for multiplex genome engineering
WO2020198212A1 (en) 2019-03-27 2020-10-01 Bunge Global Innovation, Llc Silica adsorbent treatment for removal of chlorophyll derivatives from triacylglycerol-based oils
CN113993994A (zh) * 2019-03-28 2022-01-28 因特利亚治疗公司 用于多肽表达的多核苷酸、组合物和方法
CA3143803A1 (en) 2019-06-28 2020-12-30 F. Hoffmann-La Roche Ag Method for the production of an antibody
EP3766982A1 (en) 2019-07-18 2021-01-20 Delft Advanced Biofuels B.V. Integrated system for biocatalytically producing and recovering an organic substance
CN110491447B (zh) * 2019-08-05 2021-08-17 浙江省农业科学院 一种用于异源基因体外表达的密码子优化方法及应用
CN110873833B (zh) * 2019-12-10 2022-04-08 国网河南省电力公司洛阳供电公司 一种含分布式电源的配电网自适应故障区段定位方法
US12557825B2 (en) 2020-03-10 2026-02-24 Dsm Ip Assets B.V. Lactose reduced dairy powder
EP4015626A1 (en) 2020-12-18 2022-06-22 Isobionics B.V. Enzymes and methods for fermentative production of monoterpene esters
JP2022155412A (ja) * 2021-03-30 2022-10-13 国立大学法人 奈良先端科学技術大学院大学 植物へ導入する遺伝子の人工配列の設計システム
IL307823B2 (en) 2021-04-21 2025-11-01 Univ Zhejiang Negative-strand rna viral vector and plant genome editing method without transformation
WO2022263504A1 (en) 2021-06-17 2022-12-22 Dsm Ip Assets B.V. Improved bacillus host cell
US20240352490A1 (en) 2021-08-02 2024-10-24 Basf Se Novel production of aroma compounds with ionylideneethane synthases
EP4433507A2 (en) 2021-11-19 2024-09-25 MiroBio Limited Pd-1 antibodies and uses thereof
AU2023251091A1 (en) 2022-04-06 2024-10-10 Gilead Sciences, Inc. Engineered cd200r antibodies and uses thereof
US20250311734A1 (en) 2022-05-14 2025-10-09 Novozymes A/S Compositions and Methods for Preventing, Treating, Suppressing and/or Eliminatting Phytopathogenic Infestations and Infections
US20250304938A1 (en) 2022-05-16 2025-10-02 Dsm Ip Assets B.V. Lipolytic enzyme variants
DE102022118459A1 (de) 2022-07-22 2024-01-25 Proteolutions UG (haftungsbeschränkt) Verfahren zur optimierung einer nukleotidsequenz für die expression einer aminosäuresequenz in einem zielorganismus
CN117153253B (zh) * 2022-09-09 2024-05-07 南京金斯瑞生物科技有限公司 一种设计人源化抗体序列的方法
EP4365192A1 (en) 2022-11-04 2024-05-08 DSM IP Assets B.V. Microbial production of growth factors
WO2025012325A1 (en) 2023-07-11 2025-01-16 Dsm Ip Assets B.V. Protein arginine deiminase
WO2025099224A1 (en) 2023-11-08 2025-05-15 Dsm Ip Assets B.V. Improved enzyme variants
WO2025099225A1 (en) 2023-11-08 2025-05-15 Dsm Ip Assets B.V. Improved enzyme variants
WO2025144795A1 (en) 2023-12-28 2025-07-03 Dsm Ip Assets B.V. Cells and methods for the production of glycosylated compounds
WO2026003190A1 (en) 2024-06-27 2026-01-02 Basf Se Means and methods for alpha-farnesene production
EP4737565A1 (en) 2024-10-31 2026-05-06 Isobionics B.V. Utilization of sucrose for increased production of terpenes in rhodobacter microbial cell factories

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
EP0340878B1 (en) 1988-05-06 2001-05-16 Aventis Pharma S.A. Process for the biochemical oxidation of steroids and genetically engineered cells to be used therefor
CA1333777C (en) 1988-07-01 1995-01-03 Randy M. Berka Aspartic proteinase deficient filamentous fungi
US5082767A (en) 1989-02-27 1992-01-21 Hatfield G Wesley Codon pair utilization
EP0635574B1 (en) 1993-07-23 2003-04-23 Dsm N.V. Selection marker gene free recombinant strains, a method for obtaining them and the use of these strains
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
DK0804558T3 (da) 1994-11-08 2008-05-26 Novozymes As Tripeptidylaminopeptidase
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
CN1120235C (zh) 1996-03-27 2003-09-03 诺沃奇梅兹有限公司 碱性蛋白酶缺陷型丝状真菌
EP0979294B1 (en) 1997-04-11 2015-05-27 DSM IP Assets B.V. Gene conversion as a tool for the construction of recombinant industrial filamentous fungi
EP1002091B1 (en) * 1997-07-09 2012-02-29 Coridon Pty Limited Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
PL341760A1 (en) 1997-12-22 2001-05-07 Dsm Nv Expression cloning in mildew fungi
JP2002533133A (ja) 1998-12-23 2002-10-08 ノボザイムス アクティーゼルスカブ アスペルギルス変異体細胞におけるポリペプチドの生産方法
CN1195058C (zh) 1999-02-22 2005-03-30 诺维信公司 草酰乙酸水解酶缺陷型真菌宿主细胞
ATE469223T1 (de) 2000-03-14 2010-06-15 Novozymes As Pilz transkriptionsaktivator zur verwendung in verfahren zur herstellung von polypeptiden
ATE394496T1 (de) 2000-03-24 2008-05-15 Genencor Int Herstellung von sekretierten proteinen durch rekombinante eukaryotische zellen
WO2002064766A2 (en) 2000-12-22 2002-08-22 Janssen Pharmaceutica N.V. Bax-responsive genes for drug target identification in yeast and fungi
WO2002061173A2 (en) 2001-01-29 2002-08-08 The Board Of Regents For Oklahoma State University Advanced composite ormosil coatings
EP1231272A3 (en) 2001-02-08 2002-11-13 Laboratorios Ovejero S.A. Procedure for obtaining bovine chymosin (rennin), curd
WO2003070957A2 (en) 2002-02-20 2003-08-28 Novozymes A/S Plant polypeptide production
EP1490494A1 (en) 2002-04-01 2004-12-29 Walter Reed Army Institute of Research Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
CA2513833A1 (en) 2003-02-05 2004-08-19 Dsm Ip Assets B.V. Use of oxalate deficient aspergillus niger strains for producing a polypeptide
JP4638418B2 (ja) 2003-03-31 2011-02-23 ノボザイムス，インコーポレイティド アスペルギラス・ニガーの酵素−欠失変異体における生物学的物質の生成方法
WO2005095624A2 (en) 2004-04-02 2005-10-13 Dsm Ip Assets B.V. Filamentous fungal mutants with improved homologous recombination efficiency
JP4783359B2 (ja) 2004-04-16 2011-09-28 ディーエスエム アイピー アセッツ ビー．ブイ． 真菌細胞において遺伝子を発現させるための真菌プロモーター
DK1756145T3 (da) 2004-06-16 2014-09-29 Dsm Ip Assets Bv Produktion af polypeptider ved hjælp af forbedret sekretion
CN101094919B (zh) 2004-10-12 2014-09-03 帝斯曼知识产权资产管理有限公司 在生产多肽的方法中有用的真菌转录活化因子
AU2005293578B2 (en) 2004-10-15 2010-10-21 Dsm Ip Assets B.V. Method for production of a compound in a eukaryotic cell
AU2006207463B2 (en) 2005-01-24 2011-03-17 Dsm Ip Assets B.V. Method for producing a compound of interest in a filamentous fungal cell

Also Published As

Publication number Publication date
US20140377800A1 (en) 2014-12-25
EP2423315A1 (en) 2012-02-29
AU2007263880A1 (en) 2008-01-03
JP2009540845A (ja) 2009-11-26
JP5250850B2 (ja) 2013-07-31
US20090286280A1 (en) 2009-11-19
CA2657975A1 (en) 2008-01-03
BRPI0713795B1 (pt) 2018-03-20
US8812247B2 (en) 2014-08-19
BRPI0713795A2 (pt) 2012-11-06
ES2534282T3 (es) 2015-04-21
EA200900096A1 (ru) 2009-06-30
DK2423315T3 (en) 2015-04-13
CN101490262A (zh) 2009-07-22
WO2008000632A1 (en) 2008-01-03
CN101490262B (zh) 2012-09-26
EP2423315B1 (en) 2015-01-07
EP2035561A1 (en) 2009-03-18
EA015925B1 (ru) 2011-12-30

Similar Documents

Publication Publication Date Title
IL196496A (en) A method for producing recombinant protein
GB0625995D0 (en) Method for preparing a composition
ZA200904317B (en) Improved method for making analgesics
IL197221A (en) Method for cleaning up protein
IL201391A0 (en) Method for stabilizing a protein
GB0601961D0 (en) Method
GB0603081D0 (en) Method
GB0607317D0 (en) Method
GB0606147D0 (en) Method
IL197979A0 (en) Method for peptide synthesis
GB0724491D0 (en) A method
GB2456999B (en) Method for preparing 2-deoxy-L-ribose
GB0605323D0 (en) Method
GB0603008D0 (en) Method
IL193248A0 (en) A method for producing o-methyl-n-nitroisourea
GB0604018D0 (en) Method
GB0601699D0 (en) Method
GB0602986D0 (en) Method
GB0606954D0 (en) Method
GB0611391D0 (en) Method
TWI340345B (en) Method for selecting critical variables
GB0603036D0 (en) Method
GB0612342D0 (en) Method
GB0612014D0 (en) Method
GB0610949D0 (en) Method